Stay updated on Dupilumab in Children With Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.

Latest updates to the Dupilumab in Children With Asthma Clinical Trial page
- Check6 days agoChange DetectedUpdated the study locations: new sites were added across multiple regions (US and international). Several existing locations were removed, changing the geographic options for enrollment.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedResults for the study have been posted, including TEAEs and a range of efficacy and safety measures for the main study and the Japan sub-study through Week 64. Data include FEV1, IgE, ADA, dupilumab serum concentrations, and ACQ-IA/ACQ-5-IA outcomes.SummaryDifference3%

- Check42 days agoChange Detected- The lapse in government funding notice about potential data delays and outdated information has been removed. - It previously warned that updates and responses might be affected until appropriations are enacted.SummaryDifference0.2%

- Check56 days agoChange DetectedNo additions or deletions were detected. Observed changes appear to be non-substantive metadata updates; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange Detected- Added Cali, Colombia, 760043 as a study location and removed Santiago de Cali, Colombia, 760043.SummaryDifference0.0%

- Check77 days agoChange DetectedResults status updated from No Results Posted to Results Submitted, signaling that results are now available.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Children With Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.